Partner Therapeutics, Inc.

General Information

Identification Code: 804680091504-89

Website: www.partnertx.com

Entity Form: Corporation

Registration Category: Companies & groups

Registration Date: 3/30/2024

Mission & Interests

Goals: Partner Therapeutics is developing treatments to address unmet medical needs with a focus on hematology/oncology indications and health security/critical care. Our global focus for Health Security and Critical Care is to develop therapies that have dual use and broad spectrum potential, and includes therapies to address sepsis and acute radiation distress syndrome, autoimmune pulmonary proteinosis, and trauma that have "dual use" as treatments against chemical, biological and radiological/nuclear threats. The Company has discussed a Marketing Authorization Application (MAA) submission for its radiation exposure treatment with the European Commission Emergency Task Force and the European Medicines Agency (EMA) and was recently granted Accelerated Assessment of this submission. The MAA will be submitted to EMA no later than April 6, 2024.

Interests Represented: Promotes their own interests or the collective interests of their members

Interests:

Business and industry
Public health
Research and innovation

Levels of Interest:

global

Activities

Main EU Legislative Proposals: Regulation (EU) 2022/2371 - The Union Prevention Preparedness and Response Plan Commission Decision C(2014) 2258 - Joint Procurement Agreement to procure medical countermeasures pursuant to Decision 1082/2013/EU Funding for preparedness and stockpiling of medical countermeasures for chemical, biological, radiological and nuclear threats

Communication Activities: - Written, virtual and in-person communications and submissions to the European Medicines Agency in support of potential approval for medical countermeasures to treat chemical, biological, radiological and nuclear threats. - Written communications and virtual and in-person meetings with HERA, ECHO and rescEU regarding the need for adequate preparedness and response, potential solutions for challenges and solutions for preparedness and response to chemical, biological, radiological and nuclear threats. - Potential outreach and communication with other interested parties regarding preparedness and response.

Inter-institutional or Unofficial Groupings: N/A

Head Office

Address: 19 Muzzey Street, Suite 105

Post Code: 02421

City: Lexington

Country: UNITED STATES

Phone:

Indic Phone: 1

Phone Number: 9496370947

EU Office

Address: 19 Muzzey Street, Suite 105

Post Code: 02421

City: Lexington

Country: UNITED STATES

Phone:

Indic Phone: 1

Phone Number: 9496370947

Financial Data

Closed Year:

Start Date:

End Date:

Funding Sources:

Contributions:

Total Budget: 0

Grants:

Current Year:

Grants:

Membership Information

Members10 Percent: 2

Members: 2

Members F T E: 0.20000000298023224

Info Members: The Company has opened an office in Ireland and plans to increase its activities in the European Union if its product(s) are approved by EMA for use in patients and/or for use in the event of a chemical, biological, radiological or nuclear incident.